» Articles » PMID: 2201320

Treatment with Bovine Hyperimmune Colostrum of Cryptosporidial Diarrhea in AIDS Patients

Overview
Journal AIDS
Date 1990 Jun 1
PMID 2201320
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Cryptosporidium parvum may cause severe, debilitating diarrhea in patients with AIDS. Recent anecdotal reports have suggested that hyperimmune bovine colostrum may be effective. We conducted a double-blind, controlled pilot study of hyperimmune bovine colostrum for diarrhea due to cryptosporidiosis in five AIDS patients. The patients were randomized to receive either hyperimmune or control colostrum by continuous nasogastric infusion for 10 days. All stools were collected, graded, and weighed, and the concentration of oocysts excreted was determined daily. One of the three patients treated with hyperimmune colostrum had a reduction in diarrhea and in the concentration of oocysts excreted. A second treated patient had a modest decrease in the concentration of oocysts excreted. Two patients who received control colostrum also had decreases in the volume of diarrhea but no change in the concentration of oocysts excreted. We conclude that hyperimmune colostrum with high titers of specific anti-Cryptosporidium antibody could be effective in treating patients with cryptosporidiosis. However, more studies of cow colostral immunoglobulin need to be performed so that the efficacy of this treatment can be assessed more thoroughly.

Citing Articles

Past, current, and potential treatments for cryptosporidiosis in humans and farm animals: A comprehensive review.

Khan S, Witola W Front Cell Infect Microbiol. 2023; 13:1115522.

PMID: 36761902 PMC: 9902888. DOI: 10.3389/fcimb.2023.1115522.


Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Lee L, Samardzic K, Wallach M, Frumkin L, Mochly-Rosen D Front Immunol. 2021; 12:696003.

PMID: 34177963 PMC: 8220206. DOI: 10.3389/fimmu.2021.696003.


Identification and characterization of a new 34 kDa MORN motif-containing sporozoite surface-exposed protein, Cp-P34, unique to Cryptosporidium.

Jaskiewicz J, Tremblay J, Tzipori S, Shoemaker C Int J Parasitol. 2021; 51(9):761-775.

PMID: 33774040 PMC: 8373667. DOI: 10.1016/j.ijpara.2021.01.003.


Randomized controlled clinical trial on the effect of oral immunoglobulin supplementation on neonatal dairy calves with diarrhea.

Chung J, Rayburn M, Chigerwe M J Vet Intern Med. 2019; 33(4):1807-1813.

PMID: 31124588 PMC: 6639563. DOI: 10.1111/jvim.15538.


Delivery of SA35 and SA40 peptides in mice enhances humoral and cellular immune responses and confers protection against Cryptosporidium parvum infection.

Tosini F, Ludovisi A, Tonanzi D, Amati M, Cherchi S, Pozio E Parasit Vectors. 2019; 12(1):233.

PMID: 31092283 PMC: 6518611. DOI: 10.1186/s13071-019-3486-8.